Aptose Biosciences Inc logo

Aptose Biosciences Inc

1
NAS:APTO (Canada)  
$ 0.66 +0.005 (+0.76%) 10:08 PM EST
At Loss
P/B:
74.17
Market Cap:
$ 11.76M
Enterprise V:
$ 3.35M
Volume:
121.03K
Avg Vol (2M):
69.32K
Trade In:
Volume:
121.03K
At Loss
Avg Vol (2M):
69.32K

Business Description

Description
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
Name Current Vs Industry Vs History
Cash-To-Debt 10.15
Equity-to-Asset 0.01
Debt-to-Equity 6.72
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 21.62
9-Day RSI 23.23
14-Day RSI 24.45
6-1 Month Momentum % -61.61
12-1 Month Momentum % -80.63

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.97
Quick Ratio 0.97
Cash Ratio 0.77

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.3
Shareholder Yield % -158.75
Name Current Vs Industry Vs History
ROE % -521.85
ROA % -208.22
ROIC % -3018.54
ROC (Joel Greenblatt) % -3988.62
ROCE % -491.89

Financials (Next Earnings Date:2024-08-09 Est.)

APTO's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:APTO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Aptose Biosciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -6.2
Beta 0.79
Volatility % 61.96
14-Day RSI 24.45
14-Day ATR ($) 0.065852
20-Day SMA ($) 0.722272
12-1 Month Momentum % -80.63
52-Week Range ($) 0.59 - 5.1
Shares Outstanding (Mil) 18.11

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Aptose Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Aptose Biosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Aptose Biosciences Inc Frequently Asked Questions

What is Aptose Biosciences Inc(APTO)'s stock price today?
The current price of APTO is $0.66. The 52 week high of APTO is $5.10 and 52 week low is $0.59.
When is next earnings date of Aptose Biosciences Inc(APTO)?
The next earnings date of Aptose Biosciences Inc(APTO) is 2024-08-09 Est..
Does Aptose Biosciences Inc(APTO) pay dividends? If so, how much?
Aptose Biosciences Inc(APTO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1